Proteomic analysis allows for early detection of potential markers of metabolic impairment in very young obese children

[1]  J. Argente,et al.  El proteoma del tejido adiposo subcutáneo muestra heterogeneidad anatómica , 2013 .

[2]  E. Diamanti-Kandarakis,et al.  Proteomic biomarkers of type 2 diabetes mellitus risk in women with polycystic ovary syndrome. , 2013, European journal of endocrinology.

[3]  P. Codoñer-Franch,et al.  Vitamin D status is linked to biomarkers of oxidative stress, inflammation, and endothelial activation in obese children. , 2012, The Journal of pediatrics.

[4]  J. Argente,et al.  Serum visfatin and vaspin levels in prepubertal children: effect of obesity and weight loss after behavior modifications on their secretion and relationship with glucose metabolism , 2011, International Journal of Obesity.

[5]  J. Kopchick,et al.  Novel serum protein biomarkers indicative of growth hormone doping in healthy human subjects , 2011, Proteomics.

[6]  J. Kopchick,et al.  Identification of new biomarkers of low-dose GH replacement therapy in GH-deficient patients. , 2011, The Journal of clinical endocrinology and metabolism.

[7]  J. Argente,et al.  Effect of Weight Loss on High‐Molecular Weight Adiponectin in Obese Children , 2010, Obesity.

[8]  W. Paulus,et al.  Intravenous clusterin administration reduces myocardial infarct size in rats , 2010, European journal of clinical investigation.

[9]  C. Bouchard,et al.  Predicting adult body mass index-specific metabolic risk from childhood. , 2010, Metabolic syndrome and related disorders.

[10]  L. Frohman,et al.  Activation of the GH/IGF-1 axis by CJC-1295, a long-acting GHRH analog, results in serum protein profile changes in normal adult subjects. , 2009, Growth hormone & IGF research : official journal of the Growth Hormone Research Society and the International IGF Research Society.

[11]  A. Pfeiffer,et al.  Factors that influence retinol-binding protein 4-transthyretin interaction are not altered in overweight subjects and overweight subjects with type 2 diabetes mellitus. , 2009, Metabolism: clinical and experimental.

[12]  J. Kopchick,et al.  Perspective: proteomic approach to detect biomarkers of human growth hormone. , 2009, Growth hormone & IGF research : official journal of the Growth Hormone Research Society and the International IGF Research Society.

[13]  N. Mikhail The metabolic syndrome: Insulin resistance , 2009, Current hypertension reports.

[14]  Florian Kronenberg,et al.  Genetic-epidemiological evidence on genes associated with HDL cholesterol levels: A systematic in-depth review , 2009, Experimental Gerontology.

[15]  V. Mericq,et al.  Insulin Resistance Markers in Children , 2009, Hormone Research in Paediatrics.

[16]  I. Quaye Haptoglobin, inflammation and disease. , 2008, Transactions of the Royal Society of Tropical Medicine and Hygiene.

[17]  L. Beilin,et al.  CHILDHOOD OBESITY, HYPERTENSION, THE METABOLIC SYNDROME AND ADULT CARDIOVASCULAR DISEASE , 2008, Clinical and experimental pharmacology & physiology.

[18]  H. Tilg,et al.  Inflammatory Mechanisms in the Regulation of Insulin Resistance , 2008, Molecular medicine.

[19]  T. Egashira,et al.  Serum apolipoprotein j in health, coronary heart disease and type 2 diabetes mellitus. , 2006, Journal of atherosclerosis and thrombosis.

[20]  M. Wolzt,et al.  The Adipokine Visfatin is Markedly Elevated in Obese Children , 2006, Journal of pediatric gastroenterology and nutrition.

[21]  C. Visser,et al.  Clusterin: a protective mediator for ischemic cardiomyocytes? , 2005, American journal of physiology. Heart and circulatory physiology.

[22]  A. Levy,et al.  In Vivo and In Vitro Studies Establishing Haptoglobin as a Major Susceptibility Gene for Diabetic Vascular Disease , 2005, Vascular health and risk management.

[23]  I. Trougakos,et al.  Serum levels of the senescence biomarker clusterin/apolipoprotein J increase significantly in diabetes type II and during development of coronary heart disease or at myocardial infarction , 2002, Experimental Gerontology.

[24]  J. Fruchart,et al.  High-density lipoprotein subclasses and apolipoprotein A-I. , 1999, Clinica chimica acta; international journal of clinical chemistry.

[25]  K. Saku,et al.  Different effects of subclasses of HDL containing apoA-I but not apoA-II (LpA-I) on cholesterol esterification in plasma and net cholesterol efflux from foam cells. , 1995, Arteriosclerosis, thrombosis, and vascular biology.

[26]  J. Fruchart,et al.  Apolipoprotein A-containing lipoprotein particles: physiological role, quantification, and clinical significance. , 1992, Clinical chemistry.

[27]  W. Friedrichs,et al.  Extrahepatic expression of plasma protein genes during inflammation , 1991, Inflammation.

[28]  K J Rothman,et al.  No Adjustments Are Needed for Multiple Comparisons , 1990, Epidemiology.

[29]  P. McNamara,et al.  Serum protein binding and the role of increased alpha 1-acid glycoprotein in moderately obese male subjects. , 1984, British journal of clinical pharmacology.

[30]  J. Argente,et al.  Adipokines in childhood obesity. , 2013, Vitamins and hormones.

[31]  G. Chiocchia,et al.  Clusterin : A Multifacet Protein at the Crossroad of Inflammation and Autoimmunity , 2009 .